phosphoserine has been researched along with Heart Failure in 8 studies
Phosphoserine: The phosphoric acid ester of serine.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Y | 1 |
| Westenbroek, RE | 1 |
| Scheuer, T | 1 |
| Catterall, WA | 1 |
| Wang, Y | 1 |
| Chen, L | 1 |
| Hagiwara, N | 1 |
| Knowlton, AA | 1 |
| Sarma, S | 1 |
| Li, N | 1 |
| van Oort, RJ | 1 |
| Reynolds, C | 1 |
| Skapura, DG | 1 |
| Wehrens, XH | 2 |
| Sheikh, F | 1 |
| Ouyang, K | 1 |
| Campbell, SG | 1 |
| Lyon, RC | 1 |
| Chuang, J | 1 |
| Fitzsimons, D | 1 |
| Tangney, J | 1 |
| Hidalgo, CG | 1 |
| Chung, CS | 1 |
| Cheng, H | 2 |
| Dalton, ND | 1 |
| Gu, Y | 1 |
| Kasahara, H | 1 |
| Ghassemian, M | 1 |
| Omens, JH | 1 |
| Peterson, KL | 1 |
| Granzier, HL | 1 |
| Moss, RL | 1 |
| McCulloch, AD | 1 |
| Chen, J | 1 |
| Hamdani, N | 1 |
| Krysiak, J | 1 |
| Kreusser, MM | 1 |
| Neef, S | 1 |
| Dos Remedios, CG | 1 |
| Maier, LS | 1 |
| Krüger, M | 1 |
| Backs, J | 1 |
| Linke, WA | 1 |
| Lehnart, SE | 1 |
| Reiken, SR | 1 |
| Marks, AR | 1 |
| Xiao, B | 1 |
| Zhong, G | 1 |
| Obayashi, M | 1 |
| Yang, D | 1 |
| Chen, K | 1 |
| Walsh, MP | 1 |
| Shimoni, Y | 1 |
| Ter Keurs, H | 1 |
| Chen, SR | 1 |
| Bers, DM | 1 |
8 other studies available for phosphoserine and Heart Failure
| Article | Year |
|---|---|
Basal and β-adrenergic regulation of the cardiac calcium channel CaV1.2 requires phosphorylation of serine 1700.
Topics: Adaptation, Physiological; Adrenergic beta-Agonists; Amino Acid Substitution; Animals; Arrhythmias, | 2014 |
Regulation of heat shock protein 60 and 72 expression in the failing heart.
Topics: Animals; Binding Sites; Blotting, Western; Chaperonin 60; Chromatin Immunoprecipitation; DNA-Binding | 2010 |
Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy.
Topics: Aging; Animals; Calcium; Cardiomyopathies; Cyclic AMP-Dependent Protein Kinases; Death, Sudden; Fibr | 2010 |
Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease.
Topics: Actin Cytoskeleton; Actomyosin; Animals; Biomechanical Phenomena; Calcium Signaling; Cardiac Myosins | 2012 |
Crucial role for Ca2(+)/calmodulin-dependent protein kinase-II in regulating diastolic stress of normal and failing hearts via titin phosphorylation.
Topics: Amino Acid Sequence; Animals; Biomechanical Phenomena; Calcium-Calmodulin-Dependent Protein Kinase T | 2013 |
Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor.
Topics: Adrenergic beta-Agonists; Amino Acid Sequence; Animals; Benzylamines; Calcium-Calmodulin-Dependent P | 2004 |
Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon beta-adrenergic stimulation in normal and failing hearts.
Topics: Adrenergic beta-Agonists; Animals; Arrhythmias, Cardiac; Benzylamines; Blotting, Western; Calcium Si | 2006 |
Cardiac ryanodine receptor phosphorylation: target sites and functional consequences.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Calcium Signaling; Calcium-Calmodulin-Dependent Protein | 2006 |